Cargando…

Danicamtiv Enhances Systolic Function and Frank‐Starling Behavior at Minimal Diastolic Cost in Engineered Human Myocardium

Detalles Bibliográficos
Autores principales: Shen, Shi, Sewanan, Lorenzo R., Jacoby, Daniel L., Campbell, Stuart G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477869/
https://www.ncbi.nlm.nih.gov/pubmed/34096321
http://dx.doi.org/10.1161/JAHA.121.020860
_version_ 1784575936378699776
author Shen, Shi
Sewanan, Lorenzo R.
Jacoby, Daniel L.
Campbell, Stuart G.
author_facet Shen, Shi
Sewanan, Lorenzo R.
Jacoby, Daniel L.
Campbell, Stuart G.
author_sort Shen, Shi
collection PubMed
description
format Online
Article
Text
id pubmed-8477869
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-84778692021-10-01 Danicamtiv Enhances Systolic Function and Frank‐Starling Behavior at Minimal Diastolic Cost in Engineered Human Myocardium Shen, Shi Sewanan, Lorenzo R. Jacoby, Daniel L. Campbell, Stuart G. J Am Heart Assoc Research Letter John Wiley and Sons Inc. 2021-06-07 /pmc/articles/PMC8477869/ /pubmed/34096321 http://dx.doi.org/10.1161/JAHA.121.020860 Text en © 2021 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Letter
Shen, Shi
Sewanan, Lorenzo R.
Jacoby, Daniel L.
Campbell, Stuart G.
Danicamtiv Enhances Systolic Function and Frank‐Starling Behavior at Minimal Diastolic Cost in Engineered Human Myocardium
title Danicamtiv Enhances Systolic Function and Frank‐Starling Behavior at Minimal Diastolic Cost in Engineered Human Myocardium
title_full Danicamtiv Enhances Systolic Function and Frank‐Starling Behavior at Minimal Diastolic Cost in Engineered Human Myocardium
title_fullStr Danicamtiv Enhances Systolic Function and Frank‐Starling Behavior at Minimal Diastolic Cost in Engineered Human Myocardium
title_full_unstemmed Danicamtiv Enhances Systolic Function and Frank‐Starling Behavior at Minimal Diastolic Cost in Engineered Human Myocardium
title_short Danicamtiv Enhances Systolic Function and Frank‐Starling Behavior at Minimal Diastolic Cost in Engineered Human Myocardium
title_sort danicamtiv enhances systolic function and frank‐starling behavior at minimal diastolic cost in engineered human myocardium
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477869/
https://www.ncbi.nlm.nih.gov/pubmed/34096321
http://dx.doi.org/10.1161/JAHA.121.020860
work_keys_str_mv AT shenshi danicamtivenhancessystolicfunctionandfrankstarlingbehavioratminimaldiastoliccostinengineeredhumanmyocardium
AT sewananlorenzor danicamtivenhancessystolicfunctionandfrankstarlingbehavioratminimaldiastoliccostinengineeredhumanmyocardium
AT jacobydaniell danicamtivenhancessystolicfunctionandfrankstarlingbehavioratminimaldiastoliccostinengineeredhumanmyocardium
AT campbellstuartg danicamtivenhancessystolicfunctionandfrankstarlingbehavioratminimaldiastoliccostinengineeredhumanmyocardium